Eden Research PLC has released an update on the development of its bioinsecticide product, following the receipt of recent field trial reports. The trials, conducted in Europe and the United States, tested the developmental bioinsecticide product against aphids, spider mites, whiteflies, and other target pests at various stages of their development. The results showed strong efficacy against all life stages of these key pests, with equivalent or superior performance compared to registered biological reference products produced by leading biochemical companies.

The company's bioinsecticide product addresses a significant global market opportunity, as up to 40% of crops are lost due to plant pests and diseases annually, and the United Nations estimates that 50% more food will be needed to feed the world's growing population by 2050. Insects remain a significant challenge to farming efforts, causing both direct and indirect damage to crops, costing the global economy an estimated $70 billion a year. With conventional insecticide products facing increased regulatory scrutiny, there is a high demand for sustainable alternatives like Eden's bioinsecticide, which can provide farmers with effective, sustainable, and competitive solutions.

Sean Smith, Chief Executive Officer of Eden Research, expressed optimism about the results, stating, "These promising results further demonstrate Eden's ability to develop market-leading biological formulations at a time when conventional insecticide products are being phased out due to regulatory action." The trials, conducted by Eden and potential commercial partners, showed extremely promising efficacy and consistency in combating pests known to critically impact crop yields.

Eden Research PLC is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. The company's products are formulated with terpene active ingredients, based on natural plant defense metabolites, and have shown equal or better performance compared to conventional pesticides. Eden currently has three products on the market, including Mevalone®, Cedroz™, and Ecovelex, each targeting specific agricultural challenges.

Overall, the positive results from the bioinsecticide field trials represent a significant step in Eden's journey to bring effective, sustainable solutions to farmers and further progress against its product diversification and business growth objectives.